Use of rimonabant and N-piperidino-5-(4-bromophenyl)-1-(2,4-dichlorophenyl)-4-ethylpyrazole-3-carboxamide having cannabinoids receptor antagonistic activity to treat and prevent renal diseases e.g. diabetic nephropathies

摘要

Use of rimonabant and N-peperidino-5-(4-bromophenyl)-1-(2,4-dichlorop henyl)-4-ethylpyrazole-3-carboxamide, as cannabinoids (CB1) receptor antagonists, for the preparation of medicaments useful to treat and prevent renal diseases. - ACTIVITY : Antidiabetic; Nephrotropic. - MECHANISM OF ACTION : Cannabinoids (CB1) receptor antagonist.